Related Experiment Video
Updated: Dec 9, 2025
08:18
Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
Published on: February 8, 2022
2.7K
Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
Jasvir Virdee1, Stephanie Larcombe2, Vivek Vijay3,4
1Ophthalmology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Ophthalmology and Therapy
|September 9, 2020
Summary
Idiopathic intracranial hypertension (IIH) is increasingly recognized, with research uncovering hormonal and metabolic factors. Ongoing studies and new guidelines aim to improve diagnosis and treatment for this condition.
Area of Science:
- Neurology
- Endocrinology
- Ophthalmology
Background:
- Idiopathic intracranial hypertension (IIH) is gaining medical recognition.
- Pathophysiological research is exploring hormonal dysregulation and the metabolic neuroendocrine axis in raised intracranial pressure.
- Evolving understanding necessitates updated diagnostic and management strategies.
Purpose of the Study:
- To summarize recent advancements in the understanding and management of idiopathic intracranial hypertension (IIH).
- To highlight the identification of potential novel therapeutic targets.
- To reflect changes in diagnostic criteria and clinical guidelines.
Main Methods:
- Review of current medical literature and ongoing research in IIH.
- Analysis of published randomized clinical trials.
- Incorporation of newly established consensus guidelines and modified diagnostic criteria.
Main Results:
- Increased evidence and appreciation for IIH in clinical practice.
- Identification of hormonal and metabolic neuroendocrine factors contributing to IIH.
- Publication of the first consensus guidelines for adult IIH investigation and management.
- Modification of International Headache Society criteria for IIH-related headache.
Conclusions:
- Novel therapeutic targets for IIH are emerging from research into its underlying pathology.
- Updated guidelines and criteria reflect a growing understanding of IIH.
- Continued research and clinical trials are advancing the field of IIH.
Related Concept Videos
01:25Glaucoma: Overview
1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
01:27Open Angle Glaucoma: Treatment
864
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
864
01:28Angle Closure Glaucoma: Treatment
996
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
996